Beijing, China — New research highlights a concerning trend regarding cervical cancer risk among women over the age of 65, suggesting that routine screenings for this demographic may be crucial in preventing the disease. The World Health Organization (WHO) reported approximately 660,000 cases and 350,000 deaths from cervical cancer globally in 2022, primarily caused by human papillomavirus (HPV).
HPV accounts for roughly 95% of cervical cancer cases, resulting from abnormal cell growth in the cervix that can escalate to tumors. The WHO’s strategic goal includes vaccinating 90% of girls by age 15, screening 70% of women, and treating 90% of those with cervical disease by the year 2030. These initiatives aim to prevent an estimated 62 million deaths and nearly 74 million new cases of cervical cancer by 2120.
Current guidelines in many countries often recommend that women stop cervical cancer screenings after 65 if prior results have been normal. However, the incidence of cervical cancer among this age group is increasing, with over 157,000 new cases and around 124,000 deaths reported globally in 2022 for women aged 65 and older.
A comprehensive study published in Gynecology and Obstetrics Clinical Medicine analyzed data from over two million cervical cancer screenings in China between 2017 and 2023. The findings indicated a higher prevalence of both high-risk HPV infections and abnormal cell results in women aged 65 and over compared to younger counterparts. Nearly 14% of women in this age group tested positive for high-risk HPV strains, in contrast to 8% of younger women.
Researchers stress the importance of these findings, suggesting that many older women may remain under-screened or not vaccinated at all, which boosts their risk of developing cervical cancer. As life expectancy rises, this demographic’s cancer risk becomes increasingly pertinent. Study authors called for urgent reassessment of screening protocols for women aged 65 and older, noting that the situation is different for them compared to younger women, who are often considered at lower risk after adequate screenings.
Health advocates have reacted to the study, emphasizing the need for increased vigilance among women over 65. Athena Lamnisos, CEO of the Eve Appeal cancer charity, pointed out that many in this age group may not have received adequate screenings or vaccinations. She urged the National Screening Committee to reconsider existing guidelines.
Maxine Lenza, health information manager at Cancer Research UK, stated that recent advancements in screening technology make it a highly effective method for preventing cervical cancer. Women over 65 are encouraged to stay up to date with their screenings; those who have never been screened can request a test through their GP.
The NHS confirmed that its cervical screening program in England is guided by expert recommendations. Women who test positive for HPV at 65 receive additional screenings to monitor their risk. Health officials stress the importance of attending screenings to ensure protection against cervical cancer.
In response to growing concerns, a Department of Health and Social Care spokesperson noted that women worried about their symptoms should consult their GP for personalized advice. Efforts to boost screening participation are underway, which include offering HPV self-sampling kits to remove barriers to accessing healthcare for eligible women.